Goodwin Procter

The Big Molecule Watch is monitoring clinical trial activities involving infliximab.  Here we report on recent studies with Celltrion’s INFLECTRA (infliximab-dyyb).
Earlier this year, clinical trial data was published from an observational real-world study of patients with inflammatory bowel disease,